EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Prostacyclin and heparin during hemodialysis comparative effects






Life Support Systems 4(3): 205-209

Prostacyclin and heparin during hemodialysis comparative effects

Haemodialysis was performed using heparin (dialysis I: heparin regimen 1, 2000 U/h) in ten patients. These subjects were then given an infusion of prostacyclin, in the form of epoprostenol sodium salt (dialysis II: prostacyclin, 5 ng .cntdot. kg-1 .cntdot. min-1), followed by an infusion of prostacyclin and heparin (dialysis III: heparin regimen 2, 500 U/h). Absolute platelet count, in vitro platelet aggregation and plasma beta-thromboglobulin decreased during prostacyclin infusion. Haemodialysis neutropenia was improved by prostacyclin. The membrane sieving coefficient factor and ultrafiltration volume were not improved by prostacyclin alone (dialysis II). Prostacyclin together with heparin (dialysis III) showed, 60 minutes after the start, an unchanged sieving coefficient factor compared with that of heparin alone, while the ultrafiltration volume significantly (P < 0.001) improved. The results of this study confirm those of earlier studies and suggest that prostaglandin I2 together with low-dose heparin improve the biocompatibilty and efficiency of dialysis treatment.


Accession: 006206504

PMID: 3537544



Related references

Helmling E.; Seyfert U.T.; Albert F.W., 1986: Effects of different antithrombotic agents prostacyclin heparin cg 4203 on platelets and hemostasis during bicarbonate hemodialysis. Thrombosis Research (SUPPL 6): 145

Camici, M.; Evangelisti, L., 1986: Prostacyclin and heparin during haemodialysis: comparative effects. Haemodialysis was performed using heparin (dialysis I: heparin regimen 1, 2000 U/h) in ten patients. These subjects were then given an infusion of prostacyclin, in the form of epoprostenol sodium salt (dialysis II: prostacyclin, 5 ng X kg-1 X min-...

Kuźniewski, M.; Sułowicz, W., 1990: Evaluation of the effectiveness of hemodialysis using only heparin or prostacyclin with heparin. In ten patients treated by maintenance hemodialysis due to end-stage renal failure evaluation of dialysis efficiency was performed during the treatment with heparin alone as well as in the course of prostacyclin -heparin infusion. Statistically si...

Camici, M.; Evangelisti, L., 1992: Lipid behavior during hemodialysis using heparin and prostacyclin. Ten patients have been studied for lipidic behaviour during hemodialysis using as anticoagulant heparin and prostacyclin. Hearing has been administered at infusion rate of 2000 U/h and prostacyclin in 5 ng/kg/min. Lipidic behaviour (before and aft...

Spagnuolo, P.J.; Bass, S.H.; Smith, M.C.; Danviriyasup, K.; Dunn, M.J., 1982: Neutrophil adhesiveness during prostacyclin and heparin hemodialysis. We evaluated neutrophil adhesive function in patients undergoing chronic hemodialysis using either prostacyclin or heparin as antithrombotic agents. Patients underwent successive hemodialyses with prostacyclin (4 ng/kg/min) and heparin. There were...

Smith, M.C.; Danviriyasup, K.; Crow, J.W.; Cato, A.E.; Park, G.D.; Hassid, A.; Dunn, M.J., 1982: Prostacyclin substitution for heparin in long-term hemodialysis. We studied prostacyclin as a substitute for heparin in 12 patients who underwent maintenance hemodialysis. All subjects underwent initial hemodialysis with prostacyclin as the sole anticoagulant; 10 of the 12 were restudied during heparin hemodial...

Zusman, R.M.; Rubin, R.H.; Cato, A.E.; Cocchetto, D.M.; Crow, J.W.; Tolkoff-Rubin, N., 1981: Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent. Anticoagulation during hemodialysis is necessary to prevent clotting of the blood on contact with the dialysis membrane. Heparin is the usual anticoagulant used, but systemic anticoagulation may persist for hours, and hemorrhage is common. We succ...

Gagnon, R.F.; Leclerc, J.; Liberman, A.S.; Yared, K.; Khurana, R.; Guimond, M.C.; Vasilevsky, M., 1996: Comparative effects of unfractionated heparin and enoxaparin on hemostasis during hemodialysis. Clinical & Investigative Medicine 19(4 SUPPL ): S66

Wessel Aas T.; Berg K.J.; Wideroe T E.; Wirum E.; Nilsen T., 1984: Toxicity of plasma from hemodialysis patients treated with heparin or prostacyclin. Hemodialysis was performed in 6 uremic patients with either a bolus dose of 5000 IU heparin or prostacyclin at a constant infusion rate of 5 ng/kg per min. Clinical data, plasma triglycerides (TG), free fatty acids (FFA), platelet aggregation, whi...

Eldor, A.; Allan, G.; Weksler, B.B., 1980: Heparin-prostacyclin interactions: heparin does not modify the prostacyclin induced relaxation of coronary vasculature. Thrombosis Research 19(4-5): 719-723